Alpha-glucosidase inhibitors (AGIs) are a group of antidiabetic drugs used for the management of type 2 diabetes mellitus. This activity outlines the indications, mechanism of action, contraindications, adverse effects, monitoring, and other key elements required by healthcare professionals involved in the management of type 2 diabetes mellitus and its complications.

**Objectives:**
- Identify the mechanism of action and administration of alpha-glucosidase inhibitors.
- Describe the adverse effects and contraindications of alpha-glucosidase inhibitors.
- Review the appropriate monitoring and toxicity of alpha-glucosidase inhibitors.
- Summarize interprofessional team strategies for improving care coordination and communication to optimize the use of alpha-glucosidase inhibitors and improve outcomes.